|
|
|
Volumn 23, Issue 6, 1996, Pages 754-758
|
|
Melanoma-associated tumor antigens and their clinical relevance to immunotherapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
T LYMPHOCYTE RECEPTOR;
TUMOR ANTIGEN;
ANTIGEN PRESENTING CELL;
ANTIGENICITY;
CANCER IMMUNOTHERAPY;
CARCINOGENESIS;
DISEASE COURSE;
HUMAN;
IMMUNE RESPONSE;
IMMUNOGENICITY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOMODULATION;
MELANOMA;
PATHOGENESIS;
PRIORITY JOURNAL;
REVIEW;
T LYMPHOCYTE ACTIVATION;
TREATMENT OUTCOME;
TUMOR DIFFERENTIATION;
ANTIGEN PRESENTATION;
ANTIGENS, NEOPLASM;
CANCER VACCINES;
HLA-A ANTIGENS;
HUMANS;
IMMUNOTHERAPY;
LYMPHOCYTE ACTIVATION;
MELANOMA;
NEOPLASM PROTEINS;
T-LYMPHOCYTES, CYTOTOXIC;
TUMOR ESCAPE;
|
|
EID: 0030462962
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (34)
|
|
References (0)
|
